EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Peptide Inhibitors Targeting FOXO4-p53 Interactions and Inducing Senescent Cancer Cell-specific Apoptosis

Donghoon Kang, Yeji Lim, Dabin Ahn, Jaeseok Lee iD, Chin-Ju Park iD

Journal of Medicinal Chemistry · 2025

DOI: 10.1021/acs.jmedchem.5c00537 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Donghoon Kang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea. Hauptthemen laut MEDLINE: Cellular Senescence, Tumor Suppressor Protein p53, Apoptosis, Forkhead Transcription Factors. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Yuhan, Korea Basic Science Institute, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cellular senescence, marked by irreversible cell cycle arrest and senescence-associated secretory phenotype, contributes to aging and cancer recurrence. While chemotherapy can induce senescence in cancer cells, these therapy-induced senescent cells often resist apoptosis and promote tumor recurrence. The nuclear interaction between FOXO4 and p53 is crucial for senescent cell survival. Using NMR spectroscopy, we identified that hydrophobic interactions in the p53 transactivation domain play a key role in FOXO4 forkhead domain binding. Based on this structural information, we designed an optimized peptide inhibitor with reduced negative charges and incorporated a cationic cell-penetrating peptide for enhanced cellular delivery (CPP-CAND). CPP-CAND exhibited high selectivity for senescent cells, effectively disrupting nuclear FOXO4-p53 foci and inducing caspase-dependent apoptosis. Notably, it showed cytotoxicity against senescent cancer cells induced by different chemotherapeutic agents including doxorubicin and cisplatin. With its enhanced selectivity, l-amino acid composition, and shorter length, CPP-CAND represents a promising therapeutic candidate for targeting therapy-induced senescent cancer cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cellular SenescenceTumor Suppressor Protein p53ApoptosisForkhead Transcription FactorsAntineoplastic AgentsCell-Penetrating PeptidesTranscription FactorsHumansCell Cycle ProteinsCell Line, TumorProtein BindingStructure-Activity Relationship

Substanzen

Tumor Suppressor Protein p53Forkhead Transcription FactorsFOXO4 protein, humanAntineoplastic AgentsCell Cycle ProteinsCell-Penetrating PeptidesTranscription Factors

Autor:innen und Institutionen

  • Department of Chemistry, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea.

ORCID-Profile: Jaeseok Lee, Chin-Ju Park

Förderung

  • Yuhan
  • Korea Basic Science Institute
  • National Research Foundation of Korea

Zitieren

APA

Kang, D., Lim, Y., Ahn, D., Lee, J., & Park, C. J. (2025). Peptide Inhibitors Targeting FOXO4-p53 Interactions and Inducing Senescent Cancer Cell-specific Apoptosis. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c00537

Vancouver

Kang D, Lim Y, Ahn D, Lee J, Park CJ. Peptide Inhibitors Targeting FOXO4-p53 Interactions and Inducing Senescent Cancer Cell-specific Apoptosis. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.5c00537

BibTeX
@article{Kang2025,
  author = {Kang, Donghoon and Lim, Yeji and Ahn, Dabin and Lee, Jaeseok and Park, Chin-Ju},
  title = {Peptide Inhibitors Targeting FOXO4-p53 Interactions and Inducing Senescent Cancer Cell-specific Apoptosis},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  doi = {10.1021/acs.jmedchem.5c00537}
}
Kostenlos starten →